Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia NCT00002549 Leukemia
filgrastim
busulfan
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
idarubicin
mesna
mitoxantrone hy...
allogeneic bone...
autologous bone...
peripheral bloo...
radiation thera...
15 Years - 60 Years National Cancer Institute (NCI) View Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia NCT00002785 Leukemia
filgrastim
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
mesna
methotrexate
methylprednisol...
pegaspargase
prednisone
therapeutic hyd...
vincristine sul...
allogeneic bone...
low-LET cobalt-...
low-LET photon ...
- 1 Year Children's Oncology Group View Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma NCT00002985 Sarcoma
daunorubicin hy...
pegylated lipos...
- Roswell Park Cancer Institute View Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01238211 Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Core Binding Fa...
Secondary Acute...
Therapy-Related...
Cytarabine
Dasatinib
Daunorubicin Hy...
Laboratory Biom...
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia NCT00004128 Leukemia
aldesleukin
filgrastim
busulfan
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
autologous bone...
peripheral bloo...
radiation thera...
15 Years - 60 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma NCT00408005 T Acute Lymphob...
T Lymphoblastic...
Asparaginase
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years National Cancer Institute (NCI) View 6,8-Bis(Benzylthio)Octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT02472626 Untreated Adult...
6,8-Bis(benzylt...
Cytarabine
Daunorubicin Hy...
60 Years - Wake Forest University Health Sciences View Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia NCT00039117 Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Secondary Acute...
Untreated Adult...
oblimersen sodi...
cytarabine
daunorubicin hy...
laboratory biom...
pharmacological...
60 Years - National Cancer Institute (NCI) View Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma NCT00275106 Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisolone
thioguanine
vincristine sul...
radiation thera...
- 21 Years National Cancer Institute (NCI) View Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00002756 Leukemia
filgrastim
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
leucovorin calc...
mercaptopurine
methotrexate
prednisone
therapeutic hyd...
vincristine sul...
- 1 Year Children's Oncology Group View Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia NCT01627041 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Alkylating Agen...
Secondary Acute...
Cytarabine
Daunorubicin Hy...
Decitabine
Laboratory Biom...
Pharmacological...
18 Years - 65 Years National Cancer Institute (NCI) View Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia NCT03900949 Acute Myeloid L...
Allogeneic Hema...
Cytarabine
Daunorubicin Hy...
Gemtuzumab Ozog...
Midostaurin
18 Years - Ohio State University Comprehensive Cancer Center View Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00002744 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 Years Children's Oncology Group View S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00066794 Leukemia
filgrastim
sargramostim
cyclosporine
cytarabine
daunorubicin hy...
56 Years - SWOG Cancer Research Network View S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00004217 Leukemia
filgrastim
sargramostim
cytarabine
daunorubicin hy...
valspodar
56 Years - SWOG Cancer Research Network View Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia NCT03900949 Acute Myeloid L...
Allogeneic Hema...
Cytarabine
Daunorubicin Hy...
Gemtuzumab Ozog...
Midostaurin
18 Years - Ohio State University Comprehensive Cancer Center View Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia NCT00550992 Leukemia
anti-thymocyte ...
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
leucovorin calc...
melphalan
mercaptopurine
methotrexate
mitoxantrone hy...
pegaspargase
prednisolone
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
allogeneic bone...
allogeneic hema...
umbilical cord ...
- 1 Year Dutch Childhood Oncology Group View Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT01256398 Acute Lymphobla...
Adult B Acute L...
Alemtuzumab
Allogeneic Hema...
Autologous Hema...
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Etoposide Phosp...
Filgrastim
Fludarabine Pho...
In Vitro-Treate...
Laboratory Biom...
Leucovorin Calc...
Melphalan
Mercaptopurine
Methotrexate
Pegfilgrastim
Pharmacological...
Tacrolimus
Vincristine Sul...
18 Years - National Cancer Institute (NCI) View Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia NCT00002704 Leukemia
filgrastim
asparaginase
cyclophosphamid...
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
liposomal cytar...
mercaptopurine
mesna
methotrexate
therapeutic hyd...
thiotepa
vincristine sul...
low-LET electro...
low-LET photon ...
- 20 Years National Cancer Institute (NCI) View Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00124644 Leukemia
cytarabine
daunorubicin hy...
etoposide
tipifarnib
chemotherapy
enzyme inhibito...
high-dose chemo...
18 Years - 59 Years National Cancer Institute (NCI) View Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia NCT00004215 Anemia
Leukemia
Neutropenia
Thrombocytopeni...
filgrastim
leridistim
cytarabine
daunorubicin hy...
55 Years - Memorial Sloan Kettering Cancer Center View Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations NCT02883049 B Acute Lymphob...
B Acute Lymphob...
Central Nervous...
Testicular Leuk...
Clofarabine
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Etoposide
Hydrocortisone ...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 31 Years National Cancer Institute (NCI) View Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia NCT00002704 Leukemia
filgrastim
asparaginase
cyclophosphamid...
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
liposomal cytar...
mercaptopurine
mesna
methotrexate
therapeutic hyd...
thiotepa
vincristine sul...
low-LET electro...
low-LET photon ...
- 20 Years National Cancer Institute (NCI) View Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01349972 Acute Myeloid L...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
alvocidib
daunorubicin hy...
mitoxantrone hy...
cytarabine
18 Years - 70 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia NCT00002532 Leukemia
filgrastim
asparaginase
cytarabine
daunorubicin hy...
dexamethasone
etoposide
idarubicin
ifosfamide
leucovorin calc...
methotrexate
prednisolone
vindesine
15 Years - 65 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma NCT00408005 T Acute Lymphob...
T Lymphoblastic...
Asparaginase
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00002744 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 Years Children's Oncology Group View Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00742625 Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Untreated Adult...
daunorubicin hy...
cytarabine
bortezomib
60 Years - 75 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma NCT00002471 Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
methotrexate
methylprednisol...
therapeutic hyd...
thiotepa
vincristine sul...
- Memorial Sloan Kettering Cancer Center View Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00742625 Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Untreated Adult...
daunorubicin hy...
cytarabine
bortezomib
60 Years - 75 Years National Cancer Institute (NCI) View Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia NCT00268229 Leukemia
cytarabine
daunorubicin hy...
imatinib mesyla...
18 Years - The Cleveland Clinic View Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes NCT00454480 Leukemia
Myelodysplastic...
alemtuzumab
arsenic trioxid...
azacitidine
busulfan
clofarabine
cytarabine
daunorubicin hy...
fludarabine pho...
gemtuzumab ozog...
melphalan
tipifarnib
DNA methylation...
cytogenetic ana...
gene expression...
mutation analys...
diagnostic labo...
immunologic tec...
allogeneic hema...
nonmyeloablativ...
- National Cancer Institute (NCI) View Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia NCT00002549 Leukemia
filgrastim
busulfan
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
idarubicin
mesna
mitoxantrone hy...
allogeneic bone...
autologous bone...
peripheral bloo...
radiation thera...
15 Years - 60 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia NCT00005603 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sul...
1 Year - 21 Years Children's Oncology Group View A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia NCT05955261 Acute Myeloid L...
Venetoclax
Azacitidine
Cytarabine
Gemtuzumab Ozog...
Daunorubicin Hy...
Fludarabine Pho...
Idarubicin Hydr...
Mitoxantrone Hy...
Etoposide
Gilteritinib
29 Days - 21 Years St. Jude Children's Research Hospital View Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT02971397 Acute Myeloid L...
Bone Marrow Asp...
Cytarabine
Daunorubicin Hy...
Laboratory Biom...
18 Years - Wake Forest University Health Sciences View Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations NCT02883049 B Acute Lymphob...
B Acute Lymphob...
Central Nervous...
Testicular Leuk...
Clofarabine
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Etoposide
Hydrocortisone ...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 31 Years National Cancer Institute (NCI) View Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome NCT02521493 Acute Myeloid L...
Down Syndrome
Myelodysplastic...
Myeloid Leukemi...
Myeloproliferat...
Asparaginase
Asparaginase Er...
Cytarabine
Daunorubicin Hy...
Etoposide
Laboratory Biom...
Mitoxantrone Hy...
Thioguanine
91 Days - 3 Years Children's Oncology Group View Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia NCT00002531 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
etoposide
ifosfamide
leucovorin calc...
mercaptopurine
methotrexate
mitoxantrone hy...
prednisolone
teniposide
thioguanine
vincristine sul...
vindesine
allogeneic bone...
peripheral bloo...
radiation thera...
15 Years - 65 Years National Cancer Institute (NCI) View Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia NCT00003436 Leukemia
Myelodysplastic...
amsacrine
asparaginase
cytarabine
daunorubicin hy...
etoposide
methotrexate
mitoxantrone hy...
therapeutic hyd...
allogeneic bone...
- 15 Years National Cancer Institute (NCI) View Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia NCT00022737 Childhood Acute...
Recurrent Child...
filgrastim
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
etoposide
ifosfamide
imatinib mesyla...
leucovorin calc...
mercaptopurine ...
methotrexate
pegaspargase
vincristine sul...
allogeneic bone...
peripheral bloo...
umbilical cord ...
radiation thera...
1 Year - 21 Years National Cancer Institute (NCI) View Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma NCT00002985 Sarcoma
daunorubicin hy...
pegylated lipos...
- Roswell Park Cancer Institute View Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia NCT02003222 Acute Lymphobla...
B Acute Lymphob...
Allogeneic Hema...
Biospecimen Col...
Blinatumomab
Bone Marrow Asp...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Etoposide
Lumbar Puncture
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Rituximab
Vincristine
Vincristine Sul...
X-Ray Imaging
30 Years - 70 Years National Cancer Institute (NCI) View Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00557193 Acute Lymphobla...
Acute Undiffere...
Childhood T Acu...
Asparaginase
Biospecimen Col...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Echocardiograph...
Etoposide
Filgrastim
Laboratory Biom...
Lestaurtinib
Leucovorin Calc...
Mercaptopurine
Methotrexate
Methylprednisol...
Multigated Acqu...
Pegaspargase
Pharmacological...
Prednisone
Therapeutic Hyd...
Vincristine Sul...
- 1 Year Children's Oncology Group View Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients NCT02835222 Untreated Adult...
Cytarabine
Daunorubicin Hy...
Selinexor
18 Years - Wake Forest University Health Sciences View Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes NCT00096135 Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
methotrexate
pegaspargase
therapeutic hyd...
vincristine sul...
radiation thera...
18 Months - 29 Years Children's Oncology Group View Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients NCT02835222 Untreated Adult...
Cytarabine
Daunorubicin Hy...
Selinexor
18 Years - Wake Forest University Health Sciences View Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma NCT00004228 Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 30 Years Children's Oncology Group View PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00093600 Acute Myeloid L...
cytarabine
daunorubicin hy...
midostaurin
18 Years - 60 Years Novartis View BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia NCT04214249 Acute Myeloid L...
Acute Myeloid L...
Acute Myeloid L...
Secondary Acute...
Biospecimen Col...
Bone Marrow Asp...
Bone Marrow Bio...
Computed Tomogr...
Cytarabine
Daunorubicin Hy...
Echocardiograph...
Hematopoietic C...
Idarubicin Hydr...
Multigated Acqu...
Pembrolizumab
Punch Biopsy
18 Years - 75 Years National Cancer Institute (NCI) View Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia NCT00002658 Leukemia
Neutropenia
filgrastim
amsacrine
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
idarubicin
mitoxantrone hy...
thioguanine
tretinoin
allogeneic bone...
autologous bone...
peripheral bloo...
radiation thera...
15 Years - National Cancer Institute (NCI) View Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations NCT02323607 Recurrent Adult...
Secondary Acute...
Therapy-Related...
Untreated Adult...
Pacritinib
Cytarabine
Daunorubicin Hy...
Decitabine
Laboratory Biom...
Pharmacological...
18 Years - Ohio State University Comprehensive Cancer Center View Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome NCT00002798 Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Secondary Myelo...
Untreated Child...
asparaginase
daunorubicin hy...
fludarabine pho...
therapeutic hyd...
allogeneic bone...
3-dimensional c...
filgrastim
cytarabine
idarubicin
dexamethasone
thioguanine
etoposide
methotrexate
cyclophosphamid...
aldesleukin
busulfan
- 21 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia NCT00002812 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
idarubicin
mercaptopurine
methotrexate
pegaspargase
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 21 Years Children's Oncology Group View Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia NCT00061945 Acute Undiffere...
B-cell Adult Ac...
B-cell Childhoo...
L1 Adult Acute ...
L1 Childhood Ac...
L2 Adult Acute ...
L2 Childhood Ac...
Philadelphia Ch...
Philadelphia Ch...
Philadelphia Ch...
T-cell Adult Ac...
T-cell Childhoo...
Untreated Adult...
Untreated Child...
allopurinol
cyclophosphamid...
daunorubicin hy...
vincristine sul...
dexamethasone
asparaginase
filgrastim
imatinib mesyla...
methotrexate
cytarabine
trimethoprim-su...
mercaptopurine
leucovorin calc...
alemtuzumab
acyclovir
laboratory biom...
pharmacological...
15 Years - National Cancer Institute (NCI) View Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia NCT00022126 Leukemia
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
methylprednisol...
pegaspargase
thioguanine
vincristine sul...
allogeneic bone...
radiation thera...
- 1 Year Children's Oncology Group View Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia NCT00006363 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia NCT00003671 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
leucovorin calc...
mercaptopurine
methotrexate
thioguanine
vincristine sul...
- 18 Years Children's Oncology Group View Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement NCT02828358 Acute Leukemia ...
B Acute Lymphob...
Mixed Phenotype...
Azacitidine
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Hydrocortisone ...
Laboratory Biom...
Leucovorin
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Pharmacological...
Prednisolone
Thioguanine
Vincristine
Vincristine Sul...
- 364 Days National Cancer Institute (NCI) View Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia NCT00276601 Leukemia
arsenic trioxid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
tretinoin
5 Years - 74 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia NCT00276601 Leukemia
arsenic trioxid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
tretinoin
5 Years - 74 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia NCT02003222 Acute Lymphobla...
B Acute Lymphob...
Allogeneic Hema...
Biospecimen Col...
Blinatumomab
Bone Marrow Asp...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Etoposide
Lumbar Puncture
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Rituximab
Vincristine
Vincristine Sul...
X-Ray Imaging
30 Years - 70 Years National Cancer Institute (NCI) View Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00814164 Leukemia
clofarabine
daunorubicin hy...
cytogenetic ana...
protein express...
immunologic tec...
pharmacological...
60 Years - 120 Years Roswell Park Cancer Institute View Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes NCT00096135 Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
methotrexate
pegaspargase
therapeutic hyd...
vincristine sul...
radiation thera...
18 Months - 29 Years Children's Oncology Group View Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia NCT00003934 Adult Acute Mye...
Adult Acute Pro...
Childhood Acute...
Untreated Adult...
Untreated Child...
tretinoin
daunorubicin hy...
cytarabine
mercaptopurine
methotrexate
arsenic trioxid...
- National Cancer Institute (NCI) View Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma NCT00018954 Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
doxorubicin hyd...
etoposide
ifosfamide
mercaptopurine
methotrexate
prednisone
vincristine sul...
conventional su...
radiation thera...
- National Institutes of Health Clinical Center (CC) View Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia NCT00002700 Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
mitoxantrone hy...
prednisolone
prednisone
therapeutic hyd...
vincristine sul...
allogeneic bone...
autologous bone...
radiation thera...
15 Years - 60 Years European Organisation for Research and Treatment of Cancer - EORTC View Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia NCT00075725 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia NCT03150693 B Acute Lymphob...
Allopurinol
Cytarabine
Daunorubicin Hy...
Vincristine Sul...
Dexamethasone
Pegylated L-Asp...
Methotrexate
Bone Marrow Asp...
Cyclophosphamid...
Mercaptopurine
Rituximab
Doxorubicin
Thioguanine
Inotuzumab Ozog...
Laboratory Biom...
18 Years - 39 Years Alliance for Clinical Trials in Oncology View Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia NCT00004056 Leukemia
filgrastim
asparaginase
cytarabine
daunorubicin hy...
melphalan
thioguanine
peripheral bloo...
- 21 Years Children's Oncology Group View Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00720109 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Asparaginase
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Etoposide
Filgrastim
Hydrocortisone ...
Ifosfamide
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Methylprednisol...
Pegaspargase
Prednisone
Radiation Thera...
Vincristine Sul...
2 Years - 30 Years National Cancer Institute (NCI) View Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00814164 Leukemia
clofarabine
daunorubicin hy...
cytogenetic ana...
protein express...
immunologic tec...
pharmacological...
60 Years - 120 Years Roswell Park Cancer Institute View Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) NCT00866307 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Prophylactic Cr...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia NCT00416598 Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Untreated Adult...
Autologous Bone...
Autologous Hema...
Busulfan
Cytarabine
Daunorubicin Hy...
Decitabine
Etoposide
Filgrastim
Laboratory Biom...
Pharmacological...
15 Years - 59 Years National Cancer Institute (NCI) View Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy NCT00070174 Leukemia
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
methotrexate
mitoxantrone hy...
allogeneic bone...
- Children's Oncology Group View Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia NCT00003700 Leukemia
G-CSF
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
vincristine sul...
Allopurinol
15 Years - Alliance for Clinical Trials in Oncology View Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma NCT00002691 Lymphoma
filgrastim
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mesna
methotrexate
vincristine sul...
- 21 Years Memorial Sloan Kettering Cancer Center View Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia NCT00075725 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00372593 Leukemia
asparaginase
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
mitoxantrone hy...
- 29 Years Children's Oncology Group View Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia NCT00003436 Leukemia
Myelodysplastic...
amsacrine
asparaginase
cytarabine
daunorubicin hy...
etoposide
methotrexate
mitoxantrone hy...
therapeutic hyd...
allogeneic bone...
- 15 Years National Cancer Institute (NCI) View